Interactive Strength (TRNR) shares soared 31% after the company unveiled Tuesday CLMBR fitness equipment installations in Saudi Arabia.
More than 24.4 million shares traded intraday compared with a daily average of about 146,000.
Piper Sandler upgraded Aclaris Therapeutics (ACRS) to overweight with a price target of $13.
The move comes as Aclaris said it acquired global development rights outside of China for potential anti-TSLP monoclonal and bispecific antibodies directed against both TSLP and IL4R developed by Chinese biotech firm Biosion.
Shares of Aclaris catapulted 50% as intraday trading volume soared to more than 48.4 million from a daily average of about 1.03 million.
Invizyne Technologies (IZTC) said Tuesday that it received a $2 million project to enable enzyme production for cell-free biomanufacturing of sustainable aviation fuel.
Shares jumped 12%, with intraday trading volume at over 10,400 compared with a daily average of about 45,000.
Price: 3.31, Change: +0.78, Percent Change: +30.83
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。